08.02.2022 • NewsClariantSABICSüd-Chemie

Clariant to Sell Scientific Design Stake to SABIC

Clariant has signed definitive agreements to divest its 50% stake in the joint venture that owns Scientific Design Company to its long-term joint venture partner, SABIC. The Saudi group will execute a call option raised in 2015 to acquire the stake in the business bought by Germany’s Süd-Chemie in 2003 prior to its acquisition by Clariant.

Follwing due diligence, the partners agreed to value the US-headquartered JV at $260 million, with Clariant’s 50% share thus worth $130 million. Coupled with a profit-sharing agreement that began on Jan. 1, 2021 and will end with the transaction’s closing, Clariant said this represents an attractive valuation for its stake at around 12 times Scientific Design’s 2021 expected EBITDA, assuming a mid-2022 closing.

For 2020, Scientific Design, based in Little Ferry, New Jersey, reported sales of 121 million Swiss francs. The company is engaged in the development, licensing and catalyst supply of proprietary processes for the production of ethylene oxide (EO), ethylene glycol (EO/EG), bio-ethylene, bio-EO, bio-EG, EO derivatives, polyols and maleic anhydride. It also produces proprietary catalysts and equipment for use in its own and other industrial processes.

Author: Dede Williams, Freelance Journalist

(c) Clariant
(c) Clariant

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.